We Connect the health from Japan to the world
Mohri Company Incoportion was established in 2015 as a Japanese pharmaceutical exporter, supplying a full range of premium brand and generic drugs to healthcare market worldwide. All our licensed facilities and export point in Osaka and Tokyo by ministry of health in Japan to handle exportation of OTC and prescription drugs to any qualified markets and importers in the friendly countries with Japan. We are located in Central of Tokyo where is just in the central of Tokyo, Japan.

How is the Japanese Pharmaceuticals like?
The pharmaceuticals from Japan is under high standard of quality control and tested. Due to the strict management from Ministry of Health of Japan for the quality assurance. So all Japanese pharmaceuticals are serious from the manufacturing by tested result, stability and quality.
| Company Name | Mohri Company INC |
| Head Office | 1-1-7 Motoakasaka, Minato-Ku, Tokyo, Japan 〒107-0051 |
| Director | Yuki Mohri Jim [Japanese] |
| TEL | 03-6455-5992 |
| FAX | 03-4578-2051 |
| Website | http://www.mohricompany.jp |
| Business Activities | Supply for Named Patient Program, Clinical Trial, Compassionated Use, Government Tender, Contract Manufacturer |
| Description of Business | Pharmaceuticals exporter from Japan/ Clinical Trial Supply and Agent Service in Japan |
| Capital | JPY 3 Million |

Our Advantages:
- All our export from Japan is 100% regulated.
- You get product with stable quality and quantity.
- Long term deal, no supply stop or whatever any reason has no supply.
- Supply on time when necessary
We are looking for long term customers whom are interest to purchase pharmaceuticals product from Japan and we are looking forward to hear from you.
As a legal and trustworth warehouser and exporting the global standard of Japanese pharmaceutical products, Mohri Company:
• Complies with all Japan and international standard, laws and regulations for the acquisition, warehousing and
international distribution of pharmaceutical products
• Meets by regulations set forth by all appropriate rules from all governments.
• Meets or exceeds domestic and international quality assurance standards for distribution of
medicinal products for human use, including the EMA GDP guidelines of March 7th, 2013
